{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:14:57Z","timestamp":1793279697823,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110508","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:06:54Z","timestamp":1789085214000},"page":"110508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["AI-guided discovery of a brain-penetrant LILRB4 inhibitor active in microglial and 5xFAD models of Alzheimer's disease"],"prefix":"10.1016","volume":"182","author":[{"given":"Somaya A.","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa T.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2026.110508_bb0005","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.bioorg.2026.110508_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110508_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease (CLARITY AD)","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110508_bb0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer\u2019s disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2026.110508_bb0025","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110508_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003426","article-title":"Disease-associated microglia in neurodegenerative diseases: friend or foe?","volume":"23","author":"Cheng","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2026.110508_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00109-024-02504-x","article-title":"The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer\u2019s disease","volume":"103","author":"Salminen","year":"2025","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110508_bb0040","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110508_bb0045","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.110508_bb0050","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","article-title":"Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease","volume":"11","author":"Olah","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110508_bb0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/acsmedchemlett.5c00542","article-title":"AI-assisted discovery and optimization of small-molecule TREM2 agonists with functional microglial activity","volume":"17","author":"Cho","year":"2026","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110508_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500718","article-title":"Structure-based virtual screening identifies TREM2-targeted small molecules that enhance microglial phagocytosis","volume":"21","author":"Cho","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110508_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118862","article-title":"As48, a first-in-class dual-function TREM2 modulator: receptor activation and shedding inhibition","volume":"193","author":"Cho","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110508_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118358","article-title":"TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization","volume":"302","author":"Nada","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110508_bb0075","doi-asserted-by":"crossref","first-page":"18013","DOI":"10.1074\/jbc.M111.221028","article-title":"Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3\/LIR-5\/CD85k)","volume":"286","author":"Cheng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110508_bb0080","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/biology10121300","article-title":"Characterization of the leucocyte immunoglobulin-like receptor B4 (Lilrb4) expression in microglia","volume":"10","author":"Kretzschmar","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.bioorg.2026.110508_bb0085","article-title":"Leukocyte immunoglobulin-like receptor B4: a keystone in immune modulation and therapeutic target in cancer and beyond","volume":"3","author":"Lu","year":"2024","journal-title":"Cancer Innov."},{"key":"10.1016\/j.bioorg.2026.110508_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-024-03206-4","article-title":"Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment","volume":"21","author":"Ma","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2026.110508_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"5123","key":"10.1016\/j.bioorg.2026.110508_bb0100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110508_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110508_bb0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"741","key":"10.1016\/j.bioorg.2026.110508_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9052","article-title":"Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model","volume":"16","author":"Hou","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.110508_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla","year":"2020","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bioorg.2026.110508_bb0125","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","article-title":"AI-driven drug discovery: a comprehensive review","volume":"10","author":"Ferreira","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110508_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110508_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"6781","key":"10.1016\/j.bioorg.2026.110508_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9530","article-title":"Deep contrastive learning enables genome-wide virtual screening","volume":"391","author":"Jia","year":"2026","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110508_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"13","key":"10.1016\/j.bioorg.2026.110508_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200776","article-title":"Structure-based drug discovery with deep learning","volume":"24","author":"\u00d6z\u00e7elik","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2026.110508_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2026.108977","article-title":"AlphaFold-based peptide structure prediction: opportunities, limitations, and future directions","volume":"92","author":"Zhang","year":"2026","journal-title":"Biotechnol. Adv."},{"issue":"6693","key":"10.1016\/j.bioorg.2026.110508_bb0160","doi-asserted-by":"crossref","first-page":"eadl2528","DOI":"10.1126\/science.adl2528","article-title":"Generalized biomolecular modeling and design with RoseTTAFold all-atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110508_bb0165","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-023-37701-8","article-title":"PeSTo: parameter-free geometric deep learning for accurate prediction of protein binding interfaces","volume":"14","author":"Krapp","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110508_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119740","article-title":"From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression","author":"Abdel-Rahman","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110508_bb0175","article-title":"Discovery of ILT3 (LILRB4) small molecule inhibitors by affinity selection-mass spectrometry reveals druggability of a neuroimmune checkpoint in Alzheimer\u2019s disease","author":"Abdel-Rahman","year":"2026","journal-title":"bioRxiv"},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110508_bb0180","doi-asserted-by":"crossref","first-page":"W466","DOI":"10.1093\/nar\/gkaf421","article-title":"PrankWeb 4: a modular web server for protein-ligand binding site prediction and downstream analysis","volume":"53","author":"Pol\u00e1k","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110508_bb0185","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/2326-6066.CIR-19-0036","article-title":"Disrupting LILRB4\/APOE interaction by an efficacious humanized antibody reverses T-cell suppression and blocks AML development","volume":"7","author":"Gui","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"40","key":"10.1016\/j.bioorg.2026.110508_bb0190","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:20:48Z","timestamp":1791260448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S0045206826010448"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110508","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-guided discovery of a brain-penetrant LILRB4 inhibitor active in microglial and 5xFAD models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110508"}}